Walgreens Boots Alliance Inc (NASDAQ:WBA) Shares Sold by Roundview Capital LLC

Share on StockTwits

Roundview Capital LLC lessened its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 7.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,875 shares of the pharmacy operator’s stock after selling 1,850 shares during the period. Roundview Capital LLC’s holdings in Walgreens Boots Alliance were worth $1,047,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in WBA. Private Ocean LLC bought a new position in Walgreens Boots Alliance during the 1st quarter worth approximately $25,000. Islay Capital Management LLC bought a new position in Walgreens Boots Alliance during the 4th quarter worth approximately $29,000. Americana Partners LLC bought a new position in Walgreens Boots Alliance during the 4th quarter worth approximately $29,000. Pearl River Capital LLC bought a new stake in shares of Walgreens Boots Alliance in the 1st quarter worth approximately $35,000. Finally, Bray Capital Advisors bought a new stake in shares of Walgreens Boots Alliance in the 1st quarter worth approximately $37,000. 57.19% of the stock is currently owned by institutional investors.

Shares of NASDAQ WBA traded down $0.15 during mid-day trading on Monday, reaching $39.60. The company had a trading volume of 3,391,244 shares, compared to its average volume of 7,348,387. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 1.34. The stock has a market cap of $34.74 billion, a PE ratio of 10.15, a P/E/G ratio of 1.83 and a beta of 0.55. The company has a 50-day moving average price of $42.22 and a two-hundred day moving average price of $51.33. Walgreens Boots Alliance Inc has a 1-year low of $36.65 and a 1-year high of $64.50.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, April 2nd. The pharmacy operator reported $1.52 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.46 by $0.06. The business had revenue of $35.82 billion for the quarter, compared to analysts’ expectations of $35.24 billion. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The company’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.64 EPS. On average, research analysts expect that Walgreens Boots Alliance Inc will post 5.53 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Wednesday, May 20th will be issued a $0.4575 dividend. This represents a $1.83 dividend on an annualized basis and a dividend yield of 4.62%. The ex-dividend date is Tuesday, May 19th. Walgreens Boots Alliance’s payout ratio is 30.55%.

Several analysts recently issued reports on the company. TheStreet downgraded Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a report on Tuesday, February 25th. Barclays cut their price target on Walgreens Boots Alliance from $60.00 to $50.00 and set an “equal weight” rating on the stock in a report on Friday, April 3rd. Cowen cut their price target on Walgreens Boots Alliance from $54.00 to $48.00 and set a “market perform” rating on the stock in a report on Tuesday, May 19th. UBS Group raised Walgreens Boots Alliance from a “sell” rating to a “neutral” rating and cut their target price for the company from $49.00 to $44.00 in a research note on Monday, April 6th. Finally, ValuEngine downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, March 3rd. Four investment analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $51.21.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Story: What are the advantages of the Stochastic Momentum Index?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.